Global Cancer Biomarkers Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2022

Wiseguyreports.Com Adds “Cancer Biomarkers Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”

PUNE, INDIA, August 18, 2017 /EINPresswire.com/ —

Summary

This report studies the global Cancer Biomarkers market, analyzes and researches the Cancer Biomarkers development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Abbott Laboratories
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Illumina, Inc.
Agilent Technologies
QIAGEN
Merck & Co., Inc.
Hologic, Inc.
Novartis AG
bioMérieux SA
Genomic Health, Inc.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1757902-global-cancer-biomarkers-market-size-status-and-forecast-2022

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Cancer Biomarkers can be split into
PSA Tests
CTC Tests
AFP Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others

Market segment by Application, Cancer Biomarkers can be split into
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancer
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others

At any Query @ https://www.wiseguyreports.com/enquiry/1757902-global-cancer-biomarkers-market-size-status-and-forecast-2022

Table of Contents

Global Cancer Biomarkers Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Biomarkers
1.1 Cancer Biomarkers Market Overview
1.1.1 Cancer Biomarkers Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Biomarkers Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Biomarkers Market by Type
1.3.1 PSA Tests
1.3.2 CTC Tests
1.3.3 AFP Tests
1.3.4 HER2 Tests
1.3.5 BRCA Tests
1.3.6 ALK Tests
1.3.7 CEA Tests
1.3.8 EGFR Mutation Tests
1.3.9 KRAS Mutation Tests
1.3.10 Others
1.4 Cancer Biomarkers Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Lung Cancer
1.4.3 Colorectal Cancer
1.4.4 Melanoma
1.4.5 Blood Cancer
1.4.6 Prostate Cancer
1.4.7 Ovarian Cancer
1.4.8 Stomach Cancer
1.4.9 Liver Cancer
1.4.10 Others

2 Global Cancer Biomarkers Competition Analysis by Players
2.1 Cancer Biomarkers Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Thermo Fisher Scientific Inc.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Illumina, Inc.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Agilent Technologies
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 QIAGEN
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Merck & Co., Inc.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Hologic, Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Novartis AG
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 bioMérieux SA
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Genomic Health, Inc.

4 Global Cancer Biomarkers Market Size by Type and Application (2012-2017)
4.1 Global Cancer Biomarkers Market Size by Type (2012-2017)
4.2 Global Cancer Biomarkers Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Biomarkers in Future
4.4 Top Consumer/End Users of Cancer Biomarkers

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1757902

Continued….

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire